Assessment of diabetic polyneuropathy in inpatient care: Fasting Blood Glucose, HbA1c, Electroneuromyography and Diabetes Risk Factors

Acta Informatica Medica

Volumn 21, Issue 2, 2013, Pages 123-126

  Suljic, Enra ^a   Kulasin, Igor ^a   Alibegovic, Vanja ^a  

^a UNIVERSITY OF SARAJEVO   (Bosnia and Herzegovina)

Author keywords

Diabetes mellitus; Diabetic polyneuropathy; Electroneuromyography; Enmg; Fasting blood glucose; Hba1c; Inpatient; Inpatient.

Indexed keywords

HEMOGLOBIN A1C; ORAL ANTIDIABETIC AGENT;

ADULT; AGED; ALCOHOLISM; ARTICLE; CLINICAL ARTICLE; DIABETIC NEUROPATHY; DIET RESTRICTION; DISEASE COURSE; ELECTRONEUROMYOGRAPHY; FEMALE; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HOSPITAL PATIENT; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; HYPESTHESIA; INCIDENCE; INSULIN TREATMENT; MALE; MOTOR NERVE CONDUCTION; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PARESTHESIA; PATIENT CARE; PREVALENCE; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; SMOKING;

EID: 84877878985     PISSN: 03538109     EISSN: 19865988     Source Type: Journal    
DOI: 10.5455/aim.2013.21.123-126     Document Type: Article

References (15)

1. Vrhovac B. et al. Interna medicina: Šecerna bolest., 2nd ed. Zagreb: Naprijed, 1997: 1365-1390.
2. International Diabetes Federation. Diabetes Atlas., 3rd ed. Brussels. International Diabetes Federation, 2006: 332.
3. Heljic B. et al. Diabetes mellitus. Sarajevo, Jež, 2002: 16-256.
4. Ryle C, Donaghy M. Non-enzymatic glycation of peripheral nerve proteins in human diabetics. Oxford: Institute of Molecular Medicine, 1995: 62-68.
5. Boulton AJ, Malik RA. Diabetic neuropathy. Oxford, Oxford Diabetes Library, 1998: 909-929.
6. Henry M, Kronenberg MD. Textbook of endocrinology., 11th ed. London, Saunders, 2007: 1417.
7. Harrison TR. Principi interne medicine. Placebo, Split, 1997: 1738.
8. Jušic A. Klinicka elektromioneurografija i neuromuskularne bolesti. Medicinska naklada, Zagreb, 1981: 131-133.
9. Young MJ, Boulton AJ, MacLeod AF, Williams DR, Sonksen PH. A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population. London: Diabetologia. 1993: 150-154.
10. Liu F. et al. Screening and prevalence of peripheral neuropathy in type 2 diabetic patiens: a randomized multicentre survey in 12 city hospitals of China. Shangai Diabetes Institute, 2010.
11. Morkrid K, Ali L, Hussain A. Risk factors and prevalence of diabetic peripheral neuropathy: A study of type 2 diabetic patients in Bangladesh. Int J Diabetes Dev Ctries. 2010; 30(1): 11-17.
12. Ovayolu N, Akarsu E, Madenci E, Torun S, Ucan O, Yilmaz M. Clinical characteristics of patients with diabetic polyneuropathy: the role of clinical and electromyographic evaluation and the effect of the various types on the quality of life. Int J Clin Pract. 2008 Jul; 62(7): 1019-1025.
13. Booya F. et al. Potential risk factors for diabetic neuropathy: a case control study. BMC Neurology. 2005; 5-24.
14. Boru UT. et al. Prevalence of peripheral neuropathy in type 2 diabetic patients attending a diabetes center in Turkey. Endocr J. 2007; 51: 563-567.
15. Kiziltan M, Gunduz A. Peripheral neuropathy in patiens with diabetic foot ulcers. Journal of the Neurological Sciences. 2009; 1: 75-79.